Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression

Table 1 Association between MIR31HG expression and clinical features

Clinicopathologic Variable		MIR31HG		P-value
Clinicopathologic Variable		high expression	low expression	P-value
All cases		21	21
Age(year)	≤60	12	14	0.6057
Age(year)	>60	9	7	0.6057
Gender	Male	18	16	0.4485
Gender	Female	3	5	0.4485
HBs antigen	Negative	4	5	0.4847
HBs antigen	Positive	17	16	0.4847
HCV antigen	Negative	7	8	0.7619
HCV antigen	Positive	14	13	0.7619
Serum AFP(ng/ml)	≤20	6	3	0.3009
Serum AFP(ng/ml)	>20	15	18	0.3009
Liver cirrhosis	Absence	7	4	0.3060
Liver cirrhosis	Presence	14	17	0.3060
Differentiation	Well	6	4	0.6686
	Moderate	10	12
	Poor	5	5
Alcohol intake	Absence	8	6	0.7535
Alcohol intake	Presence	13	15	0.7535
Tumor size(cm)	≤5	13	9	0.0268*
Tumor size(cm)	>5	8	12	0.0268*
Tumor nodule number	≤2	12	7	0.0477*
Tumor nodule number	>2	9	14	0.0477*
Vascular invasion	Absence	15	8	0.0332*
Vascular invasion	Presence	6	13	0.0332*
TNM	I-II	12	5	0.0308*
TNM	III-IV	9	16	0.0308*

ISSN: 1756-9966